-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, VDuYXwomIvnoeakStdhgoJU3kwpmORls1yApmDcUzJasR9RXTy2pEmG3HoDdBmh8 84MHe6ZWXq5+cfTVp33C6w== 0001209191-06-018327.txt : 20060316 0001209191-06-018327.hdr.sgml : 20060316 20060316203634 ACCESSION NUMBER: 0001209191-06-018327 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20060315 FILED AS OF DATE: 20060316 DATE AS OF CHANGE: 20060316 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: LA JOLLA PHARMACEUTICAL CO CENTRAL INDEX KEY: 0000920465 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 330361285 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 6455 NANCY RIDGE DR CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 8584526600 MAIL ADDRESS: STREET 1: 6455 NANCY RIDGE DR CITY: SAN DIEGO STATE: CA ZIP: 92121 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Gillespie Deirdre CENTRAL INDEX KEY: 0001354737 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-24274 FILM NUMBER: 06693762 BUSINESS ADDRESS: BUSINESS PHONE: 857-753-4093 MAIL ADDRESS: STREET 1: 416 MARLBOROUGH STREET STREET 2: APT. 707 CITY: BOSTON STATE: MA ZIP: 02115 4 1 doc4.xml FORM 4 SUBMISSION X0202 4 2006-03-15 0 0000920465 LA JOLLA PHARMACEUTICAL CO LJPC 0001354737 Gillespie Deirdre 6455 NANCY RIDGE DRIVE SAN DIEGO CA 92121 1 1 0 0 CEO Stock Option (right to buy) 5.26 2006-03-15 4 A 0 800000 0.00 A 2016-03-15 Common Stock 800000 800000 D The stock options vest and become exercisable with respect to 200,000 of the underlying shares on 3/15/2007. Thereafter, 1/36th of the remaining stock options vest and become exercisable each month until all options are vested. /s/ Deirdre Y. Gillespie 2006-03-16 -----END PRIVACY-ENHANCED MESSAGE-----